Perspective piece rotavirus vaccine will improve child survival by more than just preventing diarrhea: Evidence from Bangladesh

Senjuti Saha, Mathuram Santosham, Manzoor Hussain, Robert E Black, Samir K. Saha

Research output: Contribution to journalArticle

Abstract

Despite the high burden of rotavirus diarrhea, uptake of rotavirus vaccines in Asia remains low. This primarily stems from a perception of rotavirus as a non-life-threatening pathogen amidst a background of competing health priorities and limited resources. In the largest pediatric hospital of Bangladesh, where there is a fierce competition for beds, we found that between November 2015 and October 2016, 12% of 23,064 admissions were due to gastrointestinal infections, 54% of which were caused by rotavirus. One in four cases requiring hospitalization, or 5,879 cases, was refused because of unavailability of beds. Most refused cases were of pneumonia (22%), severe perinatal asphyxia (17%), preterm birth complications (7%), and meningitis (2%), all of which bear high risks of death or disability, if not treated timely. When determining vaccine policies and conducting vaccine impact studies, it would be shortsighted to not consider the impact on morbidity and mortality of cases that are refused admission because of the hospitalization of children with a preventable disease as rotavirus diarrhea. In our hospital, routine use of a rotavirus vaccine with 41% efficacy will release 629 beds per year to accommodate previously refused cases. Based on evidence, we make the case that introduction of this vaccine in Bangladesh and the surrounding region will prevent morbidity and mortality, both directly and indirectly, and help us ensure survival and well-being of all children.

Original languageEnglish (US)
Pages (from-to)360-363
Number of pages4
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume98
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Rotavirus Vaccines
Bangladesh
Rotavirus
Diarrhea
Vaccines
Hospitalization
Morbidity
Health Priorities
Pediatric Hospitals
Mortality
Asphyxia
Premature Birth
Meningitis
Pneumonia
Infection

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology

Cite this

Perspective piece rotavirus vaccine will improve child survival by more than just preventing diarrhea : Evidence from Bangladesh. / Saha, Senjuti; Santosham, Mathuram; Hussain, Manzoor; Black, Robert E; Saha, Samir K.

In: American Journal of Tropical Medicine and Hygiene, Vol. 98, No. 2, 01.01.2018, p. 360-363.

Research output: Contribution to journalArticle

@article{b9c6efbf74ac45e9bf7450ea3cc7738a,
title = "Perspective piece rotavirus vaccine will improve child survival by more than just preventing diarrhea: Evidence from Bangladesh",
abstract = "Despite the high burden of rotavirus diarrhea, uptake of rotavirus vaccines in Asia remains low. This primarily stems from a perception of rotavirus as a non-life-threatening pathogen amidst a background of competing health priorities and limited resources. In the largest pediatric hospital of Bangladesh, where there is a fierce competition for beds, we found that between November 2015 and October 2016, 12{\%} of 23,064 admissions were due to gastrointestinal infections, 54{\%} of which were caused by rotavirus. One in four cases requiring hospitalization, or 5,879 cases, was refused because of unavailability of beds. Most refused cases were of pneumonia (22{\%}), severe perinatal asphyxia (17{\%}), preterm birth complications (7{\%}), and meningitis (2{\%}), all of which bear high risks of death or disability, if not treated timely. When determining vaccine policies and conducting vaccine impact studies, it would be shortsighted to not consider the impact on morbidity and mortality of cases that are refused admission because of the hospitalization of children with a preventable disease as rotavirus diarrhea. In our hospital, routine use of a rotavirus vaccine with 41{\%} efficacy will release 629 beds per year to accommodate previously refused cases. Based on evidence, we make the case that introduction of this vaccine in Bangladesh and the surrounding region will prevent morbidity and mortality, both directly and indirectly, and help us ensure survival and well-being of all children.",
author = "Senjuti Saha and Mathuram Santosham and Manzoor Hussain and Black, {Robert E} and Saha, {Samir K.}",
year = "2018",
month = "1",
day = "1",
doi = "10.4269/ajtmh.17-0586",
language = "English (US)",
volume = "98",
pages = "360--363",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "2",

}

TY - JOUR

T1 - Perspective piece rotavirus vaccine will improve child survival by more than just preventing diarrhea

T2 - Evidence from Bangladesh

AU - Saha, Senjuti

AU - Santosham, Mathuram

AU - Hussain, Manzoor

AU - Black, Robert E

AU - Saha, Samir K.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Despite the high burden of rotavirus diarrhea, uptake of rotavirus vaccines in Asia remains low. This primarily stems from a perception of rotavirus as a non-life-threatening pathogen amidst a background of competing health priorities and limited resources. In the largest pediatric hospital of Bangladesh, where there is a fierce competition for beds, we found that between November 2015 and October 2016, 12% of 23,064 admissions were due to gastrointestinal infections, 54% of which were caused by rotavirus. One in four cases requiring hospitalization, or 5,879 cases, was refused because of unavailability of beds. Most refused cases were of pneumonia (22%), severe perinatal asphyxia (17%), preterm birth complications (7%), and meningitis (2%), all of which bear high risks of death or disability, if not treated timely. When determining vaccine policies and conducting vaccine impact studies, it would be shortsighted to not consider the impact on morbidity and mortality of cases that are refused admission because of the hospitalization of children with a preventable disease as rotavirus diarrhea. In our hospital, routine use of a rotavirus vaccine with 41% efficacy will release 629 beds per year to accommodate previously refused cases. Based on evidence, we make the case that introduction of this vaccine in Bangladesh and the surrounding region will prevent morbidity and mortality, both directly and indirectly, and help us ensure survival and well-being of all children.

AB - Despite the high burden of rotavirus diarrhea, uptake of rotavirus vaccines in Asia remains low. This primarily stems from a perception of rotavirus as a non-life-threatening pathogen amidst a background of competing health priorities and limited resources. In the largest pediatric hospital of Bangladesh, where there is a fierce competition for beds, we found that between November 2015 and October 2016, 12% of 23,064 admissions were due to gastrointestinal infections, 54% of which were caused by rotavirus. One in four cases requiring hospitalization, or 5,879 cases, was refused because of unavailability of beds. Most refused cases were of pneumonia (22%), severe perinatal asphyxia (17%), preterm birth complications (7%), and meningitis (2%), all of which bear high risks of death or disability, if not treated timely. When determining vaccine policies and conducting vaccine impact studies, it would be shortsighted to not consider the impact on morbidity and mortality of cases that are refused admission because of the hospitalization of children with a preventable disease as rotavirus diarrhea. In our hospital, routine use of a rotavirus vaccine with 41% efficacy will release 629 beds per year to accommodate previously refused cases. Based on evidence, we make the case that introduction of this vaccine in Bangladesh and the surrounding region will prevent morbidity and mortality, both directly and indirectly, and help us ensure survival and well-being of all children.

UR - http://www.scopus.com/inward/record.url?scp=85041532654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041532654&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.17-0586

DO - 10.4269/ajtmh.17-0586

M3 - Article

C2 - 29210350

AN - SCOPUS:85041532654

VL - 98

SP - 360

EP - 363

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 2

ER -